{"organizations": [], "uuid": "6433165b5bcaf6e5f9c9db5ac89b6711175f6f38", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-global-blood-therapeutics-q4-loss/brief-global-blood-therapeutics-q4-loss-per-share-0-94-idUSASB0C7TM", "country": "US", "domain_rank": 408, "title": "BRIEF-Global Blood Therapeutics Q4 Loss Per Share $0.94", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-28T00:41:00.000+02:00", "replies_count": 0, "uuid": "6433165b5bcaf6e5f9c9db5ac89b6711175f6f38"}, "author": "", "url": "https://www.reuters.com/article/brief-global-blood-therapeutics-q4-loss/brief-global-blood-therapeutics-q4-loss-per-share-0-94-idUSASB0C7TM", "ord_in_thread": 0, "title": "BRIEF-Global Blood Therapeutics Q4 Loss Per Share $0.94", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Global Blood Therapeutics Inc:\n* GBT REPORTS RECENT BUSINESS PROGRESS AND FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.94 Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-28T00:41:00.000+02:00", "crawled": "2018-02-28T00:50:28.005+02:00", "highlightTitle": ""}